Emerging Strategies in Cancer Metabolism

Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has over 20 years of teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for disease. His formulations and controlled delivery approaches are aimed at improving therapeutic outcomes. Dr. Mishra has supervised postgraduate and doctoral research scholars, has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He has won several awards including Outstanding Scientist Award, and Distinguished Professor Award. He is associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, and research. He has been recognized internationally for his research impact and scholarly contributions.Dr. Kuttiappan Anitha is working as Assistant Professor in School of Pharmacy and Technology Management (SPTM), SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Shirpur. She has broad teaching and research experience. Dr. Anitha is recipient of “Excellence in Academic Award” 2022 from International School of Technology and Sciences Affiliated from Govt. of India. She has guided more than 45 M.Pharm students and more than 10 batches of UG Projects. She has more than 30 publications in both national and international journals. Her area of expertise includes Immunooncology, endocrine areas, Gut Microbiota, infectious Diseases. She has also written several books and many book chapters. She has organized Conferences/seminars at university levels.Goutam Rath is Professor in the Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan, Bhubaneswar, India. His research focuses on nanotechnology-based systems for targeted drug and bioactive delivery, with applications in pharmaceutical development and healthcare. Prof. Rath has published extensively in peer-reviewed journals and has contributed to textbooks and book chapters in the fields of pharmaceutics and nanomedicine. His research has resulted in multiple patents, several of which have been transferred for commercial application. He supervises M.Pharm and Ph.D. researchers and serves on national expert panels and advisory groups related to biotechnology, nanomedicine, and pharmaceutical innovation.

• 1. Introduction to Gut Microbiota in Cancer Metabolism2. Cancer Metabolic Rewiring of Reactive Oxygen Species3. Emerging strategies in Cancer metabolism: Role of Gut microbiota, reactive oxygen species, and short chain fatty acids4. Exploring the Link Between Gut Microbiome and Cancer: Metabolic Implications and Therapeutic Avenue5. Oxidative Stress and Cancer Metabolism: From Pathogenesis to Therapeutic Opportunities6. Targeting ROS Signaling Pathways for Cancer Metabolic Reprogramming7. SCF Complex: Master Regulator of Metabolic Adaptations in Cancer Cells8. Manipulating gut microbial metabolites for cancer therapy: A Metabolism-centric approach9. Metabolic Crossroads: Integrating ROS, SCF and Gut Microbiota in Cancer10. Therapeutic Advances: Modulating Gut Microbiota, ROS, and SCF Pathways in Cancer Treatment11. Precision Medicine in Cancer Metabolism: Personalized Approaches Exploiting Metabolic Vulnerabilities12. Novel Biomarkers and Therapeutic Targets: Harnessing Metabolic Insights for Improved Cancer Management13. Future aspects: Novel Strategies in Cancer Metabolism Research and Clinical Interventions14. Novel approach in Bridging the Gap between Cancer Biology and Metabolism15. Implementing Gut Microbiota, ROS, and SCF Modulation in Cancer Care: Research into Practice